Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301431 · ClinicalTrials.gov registry record · Phase 2
Study Evaluating the Efficacy of DVS-233 in Fibromyalgia
A Phase 2 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1,050
- Enrollment target
NCT00301431: Clinical Trial Phase 2 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
NCT00301431 is a Phase 2 study that was terminated before completion, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 1,050 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (689% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00301431, a Phase 2 study, was terminated before completion, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1,050 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.
Interventions
- DRUG DVS-233
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,050 participants |
| Start Date | 2006-08 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Why NCT00301431 stopped before completion
NCT00301431 is an interventional study that assigns participants to a tested intervention. Its 1,050 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (689% higher).
The record links to 0 conditions, and to 1 intervention - of which DVS-233 is the first listed.
NCT00301431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00301431 about?
NCT00301431 is a clinical study titled "Study Evaluating the Efficacy of DVS-233 in Fibromyalgia". The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.
What is the current status of trial NCT00301431?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1,050 participants. The study started on 2006-08. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00301431?
The interventions under investigation include: DVS-233 (DRUG).
Who is sponsoring clinical trial NCT00301431?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00301431's enrollment target sits among peer trials
1,050 24th of 2000 higher than 1,976 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia